Less than six months after debuting as the first drug that can target a rare tumor type in patients with non-small cell lung cancer (NSCLC), Boehringer Ingelheim’s Hernexeos has quickly widened its ...
Introduction I stumbled into infosec the same year the NSA graced us with Ghidra. It’s by far become the most used tool in ...
Earnings call Ascom reported FY 2025 net revenue of CHF 292.1 million, up 4% in constant currency, and a 61% increase in EBITDA to CHF 34 million, with margin improving to 11.7%. Management guides for ...
Welcome, everybody, to Ascom's 2025 Full Year Results Conference, and also welcome to the participants that we have on the webcast. Our plan for today according to the agenda, which maybe is going to ...
Robert Kelly is managing director of XTS Energy LLC, and has more than three decades of experience as a business executive. He is a professor of economics and has raised more than $4.5 billion in ...
Why you should embrace it in your workforce by Robert D. Austin and Gary P. Pisano Meet John. He’s a wizard at data analytics. His combination of mathematical ability and software development skill is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results